| Literature DB >> 33790372 |
Krzysztof Durkalec-Michalski1,2, Emilia E Zawieja3, Bogna E Zawieja4, Tomasz Podgórski5.
Abstract
Cross-training is a high-intensity functional training (HIFT) with multiple workout modalities. Despite the increasing number of studies in HIFT, there is still no validated test to measure its specific performance. It would also be advisable to determine whether selected cross-training workouts can implement a stimulus corresponding to maximize aerobic work. For these reasons, the purpose of our study was to evaluate the repeatability and reliability of Fight Gone Bad (FGB) workout and to assess its relationship with aerobic fitness. Twenty-one cross-training participants (9 females) finished the study protocol which included three two-day measurement sessions separated by 10 days. During each session, participants had their body composition measured, and they performed two exercise tests. The first test was an incremental cycling test to measure aerobic fitness, and the second was a cross-training specific FGB workout performed the next day. Reliability and repeatability were calculated from the three measurements. The total FGB Score (FGBTOTAL) showed excellent reliability (ICC 0.9, SEM 6%). Moreover, FGBTOTAL was strongly correlated with aerobic fitness (i.e., time to exhaustion (Texh, R2 = 0.72), maximal workload (Wmax, R2 = 0.69), time to gas exchange threshold (TGET, R2 = 0.68), and peak oxygen uptake (VO2peak, R2 = 0.59). We also found that agreement between standardized FGB and standardized aerobic performance indices such as Texh, VO2peak, Wmax, maximum heart rate, TGET, and workload at gas exchange threshold was high by the Bland-Altman method. In conclusion, FGB is a reliable test that can be used in order to measure changes in cross-training performance caused by an intervention. Moreover, FGB is strongly correlated to aerobic fitness.Entities:
Year: 2021 PMID: 33790372 PMCID: PMC8012697 DOI: 10.1038/s41598-021-86660-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Repeatability of body composition measurements.
| T1 | T2 | T3 | ICC | SEM | SWC | MDC | |||
|---|---|---|---|---|---|---|---|---|---|
| Body weight (kg) | 73.0 | 73.2 | 73.1 | 0.9994 | 1.00 | < .0001 | 0.7 | 4.7 | 1.5 |
| Fat mass (kg) | 13.8 | 13.8 | 13.3 | 0.9421 | 0.97 | < .0001 | 0.8 | 1.7 | 1.6 |
| Fat-free mass (kg) | 59.2 | 59.4 | 59.8 | 0.9915 | 1.00 | < .0001 | 0.8 | 4.7 | 1.6 |
| Fat mass (%) | 19.3 | 19.3 | 18.7 | 0.9511 | 0.98 | < .0001 | 1.1 | 2.4 | 2.2 |
| Fat mass (kg) | 11.7 | 11.4 | 11.7 | 0.9553 | 0.89 | < .0001 | 1.3 | 1.2 | 2.5 |
| Fat-free mass (kg) | 61.3 | 61.7 | 61.5 | 0.9953 | 0.99 | < .0001 | 1.6 | 4.6 | 3.1 |
| Fat mass (%) | 16.4 | 16.0 | 16.4 | 0.9641 | 0.87 | < .0001 | 2.0 | 1.8 | 3.9 |
| Body water (kg) | 44.5 | 44.4 | 44.3 | 0.9979 | 0.96 | < .0001 | 2.0 | 3.3 | 4.0 |
| Body water (%) | 58.0 | 60.6 | 60.3 | 0.4066 | 0.29 | < .0001 | 5.7 | 1.7 | 11.4 |
BIA, bioelectrical impedance analysis; ICC, interclass correlation coefficient; MDC, minimal detectable change; SEM, standard error of measurement; SWC, smallest worthwhile change.
Repeatability of Fight Gone Bad performance.
| T1 | T2 | T3 | ICC | SEM | SWC | MDC | |||
|---|---|---|---|---|---|---|---|---|---|
| FGBR-1 (reps) | 104 ± 22 | 105 ± 18 | 111 ± 19 | 0.4614 | 0.91 | < .0001 | 6.4 | 7.0 | 12.6 |
| FGBR-2 (reps) | 85 ± 19 | 92 ± 16 | 91 ± 16 | 0.3295 | 0.84 | < .0001 | 7.1 | 5.8 | 14.1 |
| FGBR-3 (reps) | 81 ± 17 | 87 ± 14 | 89 ± 15 | 0.2033 | 0.78 | < .0001 | 7.7 | 5.1 | 15.1 |
| FGBTOTAL (reps) | 270 ± 57 | 284 ± 48 | 291 ± 48 | 0.3644 | 0.90 | < .0001 | 17.3 | 17.7 | 34.3 |
FGBR-1, Fight Gone Bad Round 1; FGBR-2, Fight Gone Bad Round 2; FGBR-3, Fight Gone Bad Round 3; FGBTOTAL, Fight Gone Bad total number of repetitions; ICC, interclass correlation coefficient; MDC, minimal detectable change; SEM, standard error of measurement; SWC, smallest worthwhile change.
Repeatability of heart rate during Fight Gone Bad.
| T1 | T2 | T3 | ICC | SEM | SWC | MDC | |||
|---|---|---|---|---|---|---|---|---|---|
| FGBR-1 (bpm) | 174 ± 9 | 165 ± 12 | 169 ± 14 | 0.0823 | 0.22 | 0.0970 | 8.3 | 2.2 | 16.4 |
| Rest1 (bpm) | 165 ± 13 | 159 ± 10 | 160 ± 13 | 0.2600 | 0.66 | < .0001 | 5.5 | 2.8 | 10.9 |
| FGBR-2 (bpm) | 174 ± 10 | 170 ± 11 | 172 ± 14 | 0.4928 | 0.87 | < .0001 | 3.3 | 3.1 | 6.6 |
| Rest2 (bpm) | 167 ± 13 | 163 ± 11 | 165 ± 11 | 0.5790 | 0.73 | < .0001 | 4.7 | 2.8 | 9.2 |
| FGBR-3 (bpm) | 173 ± 10 | 171 ± 9 | 173 ± 11 | 0.8607 | 0.50 | 0.0040 | 3.0 | 1.2 | 5.9 |
| Mean15min (bpm) | 173 ± 10 | 169 ± 11 | 172 ± 14 | 0.3549 | 0.79 | < .0001 | 4.4 | 3.1 | 8.8 |
| Mean17min (bpm) | 173 ± 11 | 168 ± 11 | 171 ± 13 | 0.3146 | 0.82 | < .0001 | 4.0 | 3.0 | 8.0 |
FGBR-1, Fight Gone Bad Round 1; FGBR-2, Fight Gone Bad Round 2; FGBR-3, Fight Gone Bad Round 3; Mean15min, mean of FGBR-1, FGBR-2 and FGBR-3; ICC, interclass correlation coefficient; MDC, minimal detectable change; Mean15min, mean of FGBTOTAL; SEM, standard error of measurement; Rest1, rest period between round 1 and 2; Rest2, rest period between round 2 and 3; SWC, smallest worthwhile change.
Repeatability of aerobic variables measured in incremental cycling test.
| T1 | T2 | T3 | ICC | SEM | SWC | MDC | |||
|---|---|---|---|---|---|---|---|---|---|
| Texh (min:s) | 10:34 ± 3:02 | 11:19 ± 3:04 | 11:20 ± 3:22 | 0.5980 | 0.94 | < .0001 | 0:51 | 1:08 | 1:41 |
| Wmax (W) | 254.8 ± 56.2 | 264.3 ± 59.1 | 265.5 ± 64.1 | 0.7174 | 0.95 | < .0001 | 14.5 | 21.8 | 28.8 |
| HRmax (bpm) | 172 ± 12 | 176 ± 8 | 176 ± 11 | 0.3477 | 0.49 | < .0001 | 7.6 | 2.9 | 15.0 |
| TGET (min:s) | 7:53 ± 2:09 | 8:19 ± 2:05 | 8:10 ± 2:09 | 0.5411 | 0.94 | < .0001 | 0:35 | 0:46 | 1:08 |
| WGET (W) | 207.1 ± 47.3 | 215.5 ± 43.1 | 210.7 ± 47.4 | 0.6710 | 0.93 | < .0001 | 13.2 | 16.5 | 26.0 |
| HRGET (bpm) | 163 ± 9 | 164 ± 10 | 162 ± 11 | 0.8140 | 0.79 | < .0001 | 4.4 | 3.0 | 8.8 |
| VO2GET (mL/min) | 2763 ± 675 | 2850 ± 594 | 2813 ± 657 | 0.7654 | 0.88 | < .0001 | 234 | 227 | 462 |
| VO2peak (mL/min) | 3212 ± 778 | 3256 ± 771 | 3300 ± 872 | 0.8594 | 0.96 | < .0001 | 177 | 294 | 351 |
| VCO2peak (mL/min) | 3522 ± 845 | 3684 ± 846 | 3739 ± 959 | 0.4010 | 0.92 | < .0001 | 269 | 319 | 533 |
| EE (kcal) | 126 ± 64 | 138 ± 67 | 141 ± 72 | 0.6292 | 0.96 | < .0001 | 14 | 25 | 28 |
EE, energy expenditure; HRGET, heart rate at gas exchange threshold; HRmax, maximal heart rate; ICC, interclass correlation coefficient; MDC, minimal detectable change; SEM, standard error of measurement; SWC, smallest worthwhile change; Texh, time to exhaustion; TGET, time to gas exchange threshold; VCO2peak, maximal carbon dioxide production; VO2peak, peak oxygen uptake; VO2GET, oxygen uptake at gas exchange threshold; Wmax, maximal workload; WGET, workload at gas exchange threshold.
Correlations between Fight Gone Bad performance and aerobic capacity.
| FGBR-1 | FGBR-2 | FGBR-3 | FGBTOTAL | |||||
|---|---|---|---|---|---|---|---|---|
| R2 | R2 | R2 | R2 | |||||
| Incremental cycling test | ||||||||
| Texh (min:s) | .7382 | .000 | .6981 | .000 | .6462 | .000 | .7175 | .000 |
| Wmax (W) | .7197 | .000 | .6691 | .000 | .6108 | .000 | .6899 | .000 |
| HRmax (bpm) | .3568 | .004 | .3208 | .010 | .3221 | .010 | .3442 | .006 |
| TGET (min:s) | .7051 | .000 | .6553 | .000 | .6049 | .000 | .6777 | .000 |
| WGET (W) | .6795 | .000 | .6114 | .000 | .5619 | .000 | .6401 | .000 |
| HRGET (bpm) | .2340 | .065 | .2065 | .104 | .2512 | .047 | .2364 | .062 |
| VO2GET (mL) | .5771 | .000 | .4884 | .000 | .4310 | .000 | .5195 | .000 |
| VO2peak (mL) | .6343 | .000 | .5538 | .000 | .5020 | .000 | .5851 | .000 |
| VCO2peak (mL) | .6367 | .000 | .5533 | .000 | .4927 | .000 | .5831 | .000 |
| EE (kcal) | .7361 | .000 | .6909 | .000 | .6353 | .000 | .7110 | .000 |
EE, energy expenditure; FGBR-1, Fight Gone Bad Round 1; FGBR-2, Fight Gone Bad Round 2; FGBR-3, Fight Gone Bad Round 3; FGBTOTAL, Fight Gone Bad total number of repetitions; HRGET, heart rate at gas exchange threshold; HRmax, maximal heart rate; Texh, time to exhaustion; TGET, time to gas exchange threshold; VCO2peak, maximal carbon dioxide production; VO2peak, peak oxygen uptake; VO2GET, oxygen uptake at gas exchange threshold; Wmax, maximal workload; WGET, workload at gas exchange threshold.
Figure 1Bland–Altman plots for standardized measures of Fight Gone Bad performance and aerobic capacity. FGBTOTAL, Fight Gone Bad total number of repetitions; HRmax, maximal heart rate; Texh, time to exhaustion; TGET, time to gas exchange threshold; Wmax, maximal workload; WGET, workload at gas exchange threshold; VO2peak, peak oxygen uptake.
Repeatability of hematological and biochemical parameters measured before and after Fight Gone Bad.
| T1 | T2 | T3 | ICC | SEM | SWC | MDC | |||
|---|---|---|---|---|---|---|---|---|---|
| WBC (109/L) | 8.42 ± 1.83 | 8.51 ± 1.85 | 7.92 ± 1.65 | 0.5697 | 0.63 | < .0001 | 0.48 | 1.94 | 2.92 |
| LYM (109/L) | 3.18 ± 0.94 | 3.46 ± 0.92 | 2.96 ± 0.55 | 0.2054 | 0.48 | < .0001 | 0.54 | 0.21 | 1.07 |
| MON (109/L) | 0.78 ± 0.28 | 1.04 ± 0.73 | 0.47 ± 0.16 | 0.0048 | 0.15 | 0.1020 | 0.47 | 0.11 | 0.94 |
| GRA (109/L) | 4.46 ± 1.43 | 4.0 ± 1.61 | 4.50 ± 1.36 | 0.6040 | 0.52 | < .0001 | 0.97 | 0.39 | 1.93 |
| RBC (1012/L) | 5.75 ± 0.24 | 5.84 ± 0.29 | 5.78 ± 0.28 | 0.5354 | 0.78 | < .0001 | 0.10 | 0.07 | 0.20 |
| HGB (mmol/L) | 10.31 ± 0.26 | 10.53 ± 0.45 | 10.79 ± 0.26 | 0.0003 | 0.24 | < .0001 | 0.35 | 0.09 | 0.69 |
| PLT (109/L) | 293 ± 56 | 278 ± 62 | 281 ± 64 | 0.7036 | 0.73 | < .0001 | 30.1 | 17.9 | 59.6 |
| HTC (%) | 40.78 ± 3.86 | 40.31 ± 4.38 | 39.78 ± 3.16 | 0.7118 | 0.74 | < .0001 | 0.79 | 1.04 | 1.56 |
| GLU (mg/dL) | 116 ± 16 | 126 ± 30 | 109 ± 11 | 0.0605 | 0.15 | 0.1110 | 21.3 | 5.0 | 42.3 |
| La (mmol/L) | 2.28 ± 1.56 | 1.95 ± 0.65 | 1.62 ± 0.47 | 0.1076 | 0.00 | 0.4700 | 1.01 | 0.19 | 2.00 |
| Pa (mmol/L) | 0.43 ± 0.12 | 0.38 ± 0.10 | 0.35 ± 0.07 | 0.0254 | -0.02 | 0.5400 | 0.11 | 0.02 | 0.22 |
| CK (U/L) | 313 ± 119 | 310 ± 79 | 312 ± 101 | 0.9554 | 0.45 | < .0001 | 74.0 | 27.0 | 146.5 |
| LDH (U/L) | 368 ± 98 | 345 ± 86 | 382 ± 150 | 0.7251 | 0.34 | < .0001 | 95.0 | 29.8 | 188.0 |
| WBC (109/L) | 12.41 ± 2.68 | 12.46 ± 2.15 | 12.13 ± 2.80 | 0.8811 | 0.57 | < .0001 | 1.53 | 0.68 | 3.03 |
| LYM (109/L) | 5.55 ± 1.33 | 6.03 ± 1.04 | 5.40 ± 1.25 | 0.2581 | 0.40 | < .0001 | 0.91 | 0.31 | 1.79 |
| MON (109/L) | 1.09 ± 0.37 | 1.46 ± 0.94 | 0.73 ± 0.23 | 0.0055 | 0.14 | 0.1130 | 0.61 | 0.14 | 1.21 |
| GRA (109/L) | 5.76 ± 2.04 | 4.95 ± 2.05 | 6.0 ± 1.82 | 0.3244 | 0.55 | < .0001 | 1.28 | 0.54 | 2.53 |
| RBC (1012/L) | 5.70 ± 0.24 | 5.73 ± 0.27 | 5.73 ± 0.27 | 0.9389 | 0.95 | < .0001 | 0.05 | 0.07 | 0.09 |
| HGB (mmol/L) | 10.2 ± 0.27 | 10.3 ± 0.36 | 10.6 ± 0.26 | 0.0004 | 0.28 | 0.0159 | 0.31 | 0.09 | 0.62 |
| PLT (109/L) | 333 ± 68 | 320 ± 66 | 325 ± 78 | 0.8188 | 0.61 | < .0001 | 41.1 | 19.4 | 81.4 |
| HTC (%) | 41.69 ± 3.87 | 41.81 ± 3.97 | 41.43 ± 3.42 | 0.7118 | 0.82 | < .0001 | 0.02 | 0.01 | 0.03 |
| GLU (mg/dL) | 159 ± 47 | 156 ± 48 | 161 ± 41 | 0.9581 | 0.83 | < .0001 | 18.0 | 14.2 | 35.6 |
| La (mmol/L) | 13.19 ± 3.38 | 14.25 ± 3.10 | 13.84 ± 4.59 | 0.6372 | 0.60 | < .0001 | 2.32 | 1.08 | 4.59 |
| Pa (mmol/L) | 0.80 ± 0.14 | 0.84 ± 0.16 | 0.77 ± 0.15 | 0.5136 | 0.41 | < .0001 | 0.12 | 0.04 | 0.23 |
| CK (U/L) | 330 ± 120 | 336 ± 103 | 348 ± 119 | 0.9667 | 0.52 | < .0001 | 80.3 | 32.5 | 159.1 |
| LDH (U/L) | 378 ± 83 | 394 ± 116 | 411 ± 96 | 0.6949 | 0.58 | < .0001 | 61.8 | 27.5 | 122.3 |
CK, creatine kinase; FGBPOST, after Fight Gone Bad; FGBPRE, before Fight Gone Bad; GLU, glucose; GRA, granulocytes; HGB, hemoglobin; HTC, hematocrit; ICC, interclass correlation coefficient; La, lactate; LDH, lactate dehydrogenase; LYM, lymphocytes; MON, monocytes; MDC, minimal detectable change; Pa, pyruvate; PLT, platelets; RBC, red blood cells; SEM, standard error of measurement; SWC, smallest worthwhile change; WBC, white blood cells.
Repeatability of hematological and biochemical parameters measured before and after incremental cycling test.
| T1 | T2 | T3 | ICC | SEM | SWC | MDC | |||
|---|---|---|---|---|---|---|---|---|---|
| WBC (109/L) | 7.33 ± 1.79 | 7.44 ± 1.89 | 8.35 ± 2.93 | 0.2269 | 0.57 | < .0001 | 1.47 | 0.64 | 2.92 |
| LYM (109/L) | 2.61 ± 0.62 | 2.63 ± 0.62 | 2.69 ± 0.74 | 0.8891 | 0.54 | < .0001 | 0.45 | 0.19 | 0.89 |
| MON (109/L) | 0.61 ± 0.24 | 0.54 ± 0.16 | 0.51 ± 0.24 | 0.3447 | 0.36 | 0.0031 | 0.18 | 0.06 | 0.35 |
| GRA (109/L) | 4.11 ± 1.39 | 4.28 ± 1.57 | 5.14 ± 2.76 | 0.1468 | 0.48 | < .0001 | 1.39 | 0.53 | 2.75 |
| RBC (1012/L) | 5.80 ± 0.27 | 5.83 ± 0.28 | 5.83 ± 0.28 | 0.9004 | 0.96 | < .0001 | 0.05 | 0.10 | 0.11 |
| HGB (mmol/L) | 10.57 ± 0.22 | 10.61 ± 0.19 | 10.86 ± 0.28 | 0.0004 | 0.23 | 0.0219 | 0.23 | 0.06 | 0.46 |
| PLT (109/L) | 269 ± 54 | 275 ± 57 | 271 ± 58 | 0.9654 | 0.85 | < .0001 | 22.0 | 18.6 | 43.6 |
| HTC (%) | 40.37 ± 2.87 | 40.21 ± 3.74 | 40.23 ± 2.21 | 0.9728 | 0.69 | < .0001 | 0.02 | 0.01 | 0.03 |
| GLU (mg/dL) | 105 ± 15 | 110 ± 18 | 118 ± 20 | 0.0495 | 0.08 | 0.2330 | 17.5 | 3.75 | 34.7 |
| La (mmol/L) | 1.46 ± 0.52 | 1.56 ± 0.66 | 1.75 ± 0.80 | 0.4952 | 0.43 | 0.0005 | 0.52 | 0.19 | 1.03 |
| Pa (mmol/L) | 0.35 ± 0.09 | 0.34 ± 0.08 | 0.36 ± 0.12 | 0.8226 | 0.03 | 0.4010 | 0.10 | 0.02 | 0.20 |
| CK (U/L) | 396 ± 168 | 311 ± 96 | 327 ± 147 | 0.1179 | 0.33 | 0.0040 | 115.4 | 35.4 | 228.5 |
| LDH (U/L) | 379 ± 148 | 358 ± 92 | 346 ± 97 | 0.7357 | 0.46 | 0.0003 | 85.8 | 31.8 | 170.0 |
| WBC (109/L) | 10.54 ± 2.62 | 11.80 ± 3.14 | 12.01 ± 3.39 | 0.2030 | 0.59 | < .0001 | 1.91 | 0.87 | 3.78 |
| LYM (109/L) | 4.55 ± 1.51 | 5.01 ± 1.45 | 4.80 ± 1.20 | 0.6044 | 0.47 | 0.0002 | 0.96 | 0.36 | 1.90 |
| MON (109/L) | 0.80 ± 0.29 | 0.87 ± 0.35 | 0.81 ± 0.34 | 0.8105 | 0.44 | 0.0005 | 0.24 | 0.09 | 0.48 |
| GRA (109/L) | 5.21 ± 1.53 | 5.92 ± 229 | 6.41 ± 3.3 | 0.2098 | 0.46 | 0.0002 | 1.73 | 0.63 | 3.42 |
| RBC (1012/L) | 5.77 ± 0.27 | 5.74 ± 0.27 | 5.75 ± 0.27 | 0.9815 | 0.97 | < .0001 | 0.05 | 0.09 | 0.09 |
| HGB (mmol/L) | 10.43 ± 0.26 | 10.34 ± 0.23 | 10.68 ± 0.26 | 0.0035 | 0.32 | 0.0051 | 0.23 | 0.07 | 0.45 |
| PLT (109/L) | 288 ± 59 | 303 ± 61 | 290 ± 69 | 0.7770 | 0.79 | < .0001 | 29.7 | 20.7 | 58.8 |
| HTC (%) | 42.81 ± 3.43 | 43.05 ± 3.75 | 43.12 ± 3.45 | 0.9606 | 0.88 | < .0001 | 0.01 | 0.01 | 0.02 |
| GLU (mg/dL) | 132 ± 36 | 131 ± 28 | 127 ± 24 | 0.8492 | 0.66 | < .0001 | 17.9 | 9.17 | 35.4 |
| La (mmol/L) | 11.69 ± 3.57 | 13.52 ± 2.83 | 13.35 ± 2.06 | 0.1097 | 0.56 | < .0001 | 1.94 | 0.84 | 3.84 |
| Pa (mmol/L) | 0.74 ± 0.13 | 0.78 ± 0.12 | 0.79 ± 0.10 | 0.2688 | 0.30 | 0.0112 | 0.10 | 0.03 | 0.20 |
| CK (U/L) | 399 ± 189 | 327 ± 104 | 362 ± 149 | 0.2608 | 0.37 | 0.0022 | 120.9 | 39.2 | 239.4 |
| LDH (U/L) | 365 ± 97 | 404 ± 112 | 414 ± 82 | 0.2822 | 0.33 | 0.0049 | 80.7 | 25.0 | 159.7 |
CK, creatine kinase; GLU, glucose; GRA, granulocytes; HGB, hemoglobin; HTC, hematocrit; ICC, interclass correlation coefficient; ICTPOST, after incremental cycling test; ICTPRE, before incremental cycling test; La, lactate; LDH, lactate dehydrogenase; LYM, lymphocytes; MON, monocytes; MDC, minimal detectable change; Pa, pyruvate; PLT, platelets; RBC, red blood cells; SEM, standard error of measurement; SWC, smallest worthwhile change; WBC, white blood cells.
Differences in hematological and biochemical parameters between Fight Gone Bad and incremental cycling test (means of three measurements T1–T3).
| Mean FGBPRE | Mean FGBPOST | Mean ICTPRE | Mean ICTPOST | |||||
|---|---|---|---|---|---|---|---|---|
| WBC (109/L) | 8.29 ± 1.81 | 12.30 ± 2.48 | 7.80 ± 2.24 | 11.57 ± 2.98 | < .0001 | < .0001 | 1.0000 | 1.0000 |
| LYM (109/L) | 3.20 ± 0.86 | 5.66 ± 1.21 | 2.67 ± 0.66 | 4.82 ± 1.32 | < .0001 | < .0001 | 0.0178 | 0.0139 |
| MON (109/L) | 0.75 ± 0.53 | 1.09 ± 0.68 | 0.56 ± 0.22 | 0.83 ± 0.33 | 0.0072 | 0.0023 | 0.0849 | 0.2056 |
| GRA (109/L) | 4.33 ± 1.50 | 5.53 ± 2.01 | 4.57 ± 1.92 | 5.92 ± 2.34 | 0.0703 | 0.0380 | 1.0000 | 1.0000 |
| RBC (1012/L) | 5.79 ± 0.27 | 5.72 ± 0.26 | 5.82 ± 0.28 | 5.75 ± 0.27 | ns | ns | ns | ns |
| HGB (mmol/L) | 10.55 ± 0.38 | 10.39 ± 0.35 | 10.68 ± 0.26 | 10.51 ± 0.28 | ns | ns | ns | ns |
| PLT (109/L) | 282.0 ± 61.1 | 322.8 ± 70.8 | 270.0 ± 57.1 | 291.6 ± 65.2 | ns | ns | ns | ns |
| GLU (mg/dL) | 117.2 ± 22.3 | 153.0 ± 44.6 | 111.7 ± 18.3 | 128.3 ± 30.5 | 0.0123 | 0.3068 | 1.0000 | 0.1543 |
| La (mmol/L) | 1.92 ± 1.04 | 13.41 ± 3.52 | 1.53 ± 0.69 | 12.74 ± 2.93 | < .0001 | < .0001 | 0.0605 | 1.0000 |
| Pa (mmol/L) | 0.38 ± 0.11 | 0.79 ± 0.15 | 0.35 ± 0.10 | 0.77 ± 0.12 | < .0001 | < .0001 | 0.2477 | 1.0000 |
| CK (U/L) | 307.5 ± 100.5 | 331.1 ± 112.9 | 347.7 ± 141.2 | 367.1 ± 152.1 | ns | ns | ns | ns |
| LDH (U/L) | 356.7 ± 115.3 | 385.4 ± 100.3 | 356.5 ± 116.8 | 391.5 ± 98.8 | ns | ns | ns | ns |
CK, creatine kinase; FGBPOST, after Fight Gone Bad; FGBPRE, before Fight Gone Bad; GLU, glucose; GRA, granulocytes; HGB, hemoglobin; ICTPOST, after incremental cycling test; ICTPRE, before incremental cycling test; La, lactate; LDH, lactate dehydrogenase; LYM, lymphocytes; MON, monocytes; Pa, pyruvate; PLT, platelets; RBC, red blood cells; WBC, white blood cells.
Figure 2A flow chart of the study design.